Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Experts explore possibility, practical aspects of remission of type 2 diabetes Jill Rollet
-
- ‘Counterintuitive’ glucokinase inhibition may help prevent, reverse type 2 diabetes Regina Schaffer
- Diabetes clinical trials located in few socially disadvantaged counties in US Michael Monostra
- Diabetes does not shorten cancer survival Jill Rollet
- Endocrine-disrupting chemicals may lower bone mineral density in adolescent boys Michael Monostra
- FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes Regina Schaffer
- FDA places hold on trial of novel cell therapy for type 1 diabetes
- Greater focus on self-care can reduce burnout, improve work-life balance for providers Michael Monostra
- Hypothyroidism more prevalent during late perimenopause, postmenopause Michael Monostra
-
- LOGICS: Levoketoconazole improves cortisol control in endogenous Cushing’s syndrome Jill Rollet
- Q&A: Concepts, language surrounding gender care shift over past 20 years Jill Rollet; Joshua D. Safer, MD, FACP, FACE; Vin Tangpricha, MD, PhD
- Radioactive iodine use for thyroid cancer treatment falls after 2015 ATA guidelines update Michael Monostra
- Sex hormone-binding globulin level may predict liver fibrosis for men with NAFLD Michael Monostra
- Use of high-dose biotin supplements ‘common’ among women in rural Michigan Jill Rollet
- VIDEO: AACE tailors new fatty liver guideline to endocrinologists Jonathan D. Leffert, MD, FACP, FACE, ECNU
- VIDEO: Although self-limiting, some thyroiditis should be treated Trevor Angell, MD; Caroline T. Nguyen, MD